Breast cancer encompasses various disorders with distinct histological and molecular profiles, classified into subtypes such as luminal A (hormone receptor-positive, low Ki-67), B (hormone receptor-positive, high Ki-67, negative HER2), triple-negative tumor, and tumor HER2-positive, each possessing unique genetic and clinical characteristics [4,5,6]. Here, ERBB2 is linked to neoplasm.